Whiteriver Monoclonal Antibody Project | Post COVID-19 Care | May 20, 2021

Public Health and Scientific Challenges | IHS Epidemiology Update | Monoclonal Antibodies | January 7, 2021

In this series of presentations, Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, discusses COVID-19 public health and scientific challenges. Then Dr. Michael Toedt, Medical Director for… […]

Read More… from Public Health and Scientific Challenges | IHS Epidemiology Update | Monoclonal Antibodies | January 7, 2021